Back to immunization surveillance, assesment and monitoring data
WHO Vaccine Preventable Diseases Monitoring System
Immunization indicators selection center:
These four lists are "multiselect enabled";
You are free to select any amount of any combination of items
Last update: 3 October 2011 (data as of 27-September-2011) Next overall update: June 2012
R
egion list
World
Africa
Americas
Eastern Mediterranean
Europe
South-East Asia
Western Pacific
--------------------------
C
ountry list
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia (Plurinational State of)
Bosnia and Herzegovina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Democratic People's Republic of Korea
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia (the)
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran (Islamic Republic of)
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia (Federated States of)
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of Korea
Republic of Moldova
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
The former Yugoslav Republic of Macedonia
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela (Bolivarian Republic of)
Viet Nam
Yemen
Zambia
Zimbabwe
------------------------------------------------
I
ndicator list
------------ Planning and management -------------
Nº districts are identified as poorly performing districts?
Multi-year plan (MYP) for immunization
What years does the MYP cover?
Is MYP costing included?
Was there an annual work plan for immunization services?
Annual work plan costing included?
Nº of districts with microplans that include activities to raise immunization coverage
% of districts with microplans to raise immunization coverage
Year of last inventory of all refrigeration equipment assigned for public immunization services.
Are outreach session performed at district or lower level?
Nº districts have operationalized outreach sessions?
Is supportive supervision with on-site training performed at district or lower level?
Nº districts have operationalized supportive supervision with onsite training?
Are meeting held with local leaders at district or lower level?
Nº districts have operationalized meetings with local leaders?
Is local data analysis performed at district or lower level?
Nº districts have operationalized local data analysis?
------------ National Immunization Advisory Mechanism -------------
Were the agenda and background documents distributed (at least 1 week) prior to the meetings?
Are members of the advisory group required to disclose conflict of interest?
Did the country have a standing technical advisory group on immunization?
Are there legislative or administrative basis for the advisory group?
Nº times did the advisory group meet?
Does the advisory group have formal written ToRs?
Does the advisory group have a website or webpage?
Are epidemiology experts represented in the group as core membership?
Are immunology experts represented in the group as core membership?
Are infectioous diseases experts represented in the group as core membership?
Are other experts represented in the grop as core membership? - specify
Are pediatrics represented in the group as core membership?
Are public health experts represented in the group as core membership?
------------ System performance -------------
Coverage Rpt completeness: Total number of rpts expected at national level from districts
Coverage Rpt completeness: Total number of rpts actually received at national level from districts
Total number of districts in country
% of coverage report received at national level vs number of reports expected
Nº districts had <50% DTP3 coverage
% districts had <50% DTP3 coverage
Nº districts had 50-79% DTP3
% districts had 50-79% DTP3
Nº districts had 80-89% DTP3 coverage
% districts had 80-89% DTP3 coverage
Nº districts had >=80% DTP3 coverage
% districts had >=80% DTP3 coverage
Nº districts with 90-94% DTP3 coverage
% of districts had 90-94% DTP3 coverage
Nº districts with >=95% DTP3 coverage
% of districts with >=95% DTP3
Nº districts had >=90% DTP3 coverage
% districts had >=90% DTP3 coverage
Nº districts not reporting DTP3
% districts not reporting DTP3
Nº districts had <50% MCV1 coverage
% districts had <50% MCV1 coverage
Nº districts had 50-79% MCV1 coverage
% districts had 50-79% MCV1 coverage
Nº districts had 80-89% MCV1 coverage
% districts had 80-89% MCV1 coverage
Nº districts had >=80% MCV1 coverage
% districts had >=80% MCV1 coverage
Nº districts with 90-94% MCV1 coverage
% of districts had 90-94% MCV1 coverage
Nº districts with >=95% measles (MCV1) coverage
% of districts with >=95% MCV1 coverage
Nº districts had >=90% MCV1 coverage
% districts had >=90% MCV1 coverage
Nº districts not reporting MCV1
% districts not reporting MCV1
Nº of districts with PAB coverage <50%
% of districts had <50% PAB coverage
Nº of districts with PAB coverage 50-79%
% of districts had 50-79% PAB coverage
Nº of districts with PAB coverage 80-89%
% of districts had 80-89% PAB coverage
Nº of districts with PAB coverage >=80%
% of districts had >=80% PAB coverage
Nº of districts with PAB coverage 90%-94%
% of districts had 90-94% PAB coverage
Nº of districts with PAB coverage >=95%
% of districts had >=95% PAB coverage
Nº of districts with PAB coverage >=90%
% of districts had >=90% PAB coverage
Nº of districts with non reporting PAB coverage
% districts not reporting TT2+
Nº districts had <50% TT2+ (pw) coverage
% districts had <50% TT2+ (pw) coverage
Nº districts had 50-79% TT2+ (pw)
% districts had 50-79% TT2+ (pw)
Nº districts had 80-89% TT2+ (pw) coverage
% districts had 80-89% TT2+ (pw) coverage
Nº districts had >=80% TT2+ (pw) coverage
% districts had >=80% TT2+ (pw) coverage
Nº districts with 90-94% TT2+ coverage
% of districts had 90-94% TT2+ (pw) coverage
Nº districts with >=95% TT2+ (pw) coverage
% of districts with >=95% TT2+ (pw)
Nº districts had >=90% TT2+ (pw) coverage
% districts had >=90% TT2+ (pw) coverage
Nº districts not reporting TT2plus
% districts not reporting TT2plus
Nº of districts with >10% DTP drop-out rate
% of districts had >10% drop-out rates
Drop-out rate between DTP1 and DTP3 coverage
% point difference between HepB3 and DTP3 coverage
% point difference between MCV1 and YFV coverage
------------ Surveillance -------------
Is there a surveillance system in place for invasive bacterial diseases
Is there a surveillance system in place for rotavirus diarrhoea
------------ Vaccine supply -------------
Number of districts supplied with adequate number of AD syringes for routine immunizations
Was there a stock-out at national level? (ADS)
Was there a stock-out in any district? (ADS)
Number of districts with stock-out* (ADS)
Stock-out, duration in months (ADS)
Was there a stock-out at national level? (BCG)
Was there a stock-out in any district? (BCG)
Nº of districts with stock-out* (BCG)
Stock-out, duration in months (BCG)
Was there a stock-out at national level? (DTP)
Was there a stock-out in any district? (DTP)
Number of districts with stock-out* (DTP)
Stock-out, duration in months (DTP)
Was there a stock-out at national level? (HepB)
Was there a stock-out in any district? (HepB)
Number of districts with stock-out* (HepB)
Stock-out, duration in months (HepB)
Was there a stock-out at national level? (Hib)
Was there a stock-out in any district? (Hib)
Number of districts with stock-out* (Hib)
Stock-out duration in months (Hib)
Was there a stock-out at national level? (Measles)
Was there a stock-out in any district? (Measles)
Number of districts with stock-out* (Measles)
Stock-out, duration in months (Measles)
Was there a stock-out at national level? (Penumoccocal conjugate)
Was there a stock-out in any district for Pneumococcal conjugate vaccine
Number of districts with stock-out for Pneumococcal conjugate vaccine
Stock-out duration in months - Pneumococcal conjugate vaccine
Was there a stock-out at national level? (Polio)
Was there a stock-out in any district? (Polio)
Number of districts with stock-out* (Polio)
Stock-out, duration in months (Polio)
Was there a stock-out at national level? (REC)
Was there a stock-out in any district? (REC)
Number of districts with stock-out* (REC)
Stock-out, duration in months (REC)
National level stock-out for Rotavirus
Was there a stock-out in any district for Rotavirus
Number of districts with stock-out for Rotavirus
Stock-out duration in months - Rotavirus
Was there a stock-out at national level? (SFBX)
Was there a stock-out in any district? (SFBX)
Number of districts with stock-out* (SFBX)
Stock-out, duration in months (SFBX)
Was there a stock-out at national level? (TT)
Was there a stock-out in any district? (TT)
Number of districts with stock-out* (TT)
Stock-out, duration in months (TT)
Was there a stock-out at national level? (VAD)
Was there a stock-out in any district? (VAD)
Number of districts with stock-out* (VAD)
Stock-out, duration in months (VAD)
Was there a stock-out at national level? (YF)
Was there a stock-out in any district? (YF)
Number of districts with stock-out* (YF)
Stock-out, duration in months (YF)
Was there any district with vaccine supply interruption?
% of districts supplied with sufficient number of AD syringes
------------ Vaccine wastage -------------
Is there a vaccine wastage monitoring system at service delivery level?
National % wastage for BCG
National % wastage for DTP
National % wastage for HepB
National % wastage for Hib
National % wastage for Pneumococcal conjugate
National % wastage for Rotavirus
National % wastage for Polio
National % wastage for MCV
National % wastage for Yellow Fever
National % wastage for Tetanus toxoid
------------ Safety -------------
Does your country have a vaccine adverse events review committee?
Was there a national policy for health care waste management?
Was there a national policy for waste from immunization activities?
If 2 yesses was the nat. pol. of immun. waste part of the national policy of health care waste?
immunization injection safety
medical waste management
Type of injection equipment Ad syringes
No. of districts using AD syringes Injection equipment
Type of injection equipment non AD disposables
No. of districts using Non-AD disposables Injection equipment
Type of injection equipment Sterilizables
No. of districts using Sterilisables Injection equipment
Are safety boxes distributed with all vaccine deliveries
Monitoring of Adverse Events Following Immunization (AEFI)?
Nº AEFI were reported?
Nº AEFI were categorized as "serious" adverse events
National policy regarding disposal: Incineration
National policy regarding disposal: Open burning
National policy regarding disposal: Burial
National policy regarding disposal: Other
------------ Finance -------------
Line item in national budget for vaccines
What amount of government funds were spent on vaccines
Local currency or US$ (government funds on vaccine)
Total expenditure (from all sources) on routine immunization?
Total expenditure (all sources) on routine immunization? (local currency or US$)
Total expenditure (from all sources) on vaccines used in routine immunization?
Total expenditure (all sources) on vaccines used in routine immunization? (local currency or US)
Are there line items in the national budget specifically for the health care waste management?
Percentage of routine vaccines funded by Government
Line item in national budget for injection supply
What amount of government funds were spent on routine immunization
Local currency or US$ (government funds on immunization)
Immunization spend. Financed using Government funds?
Percentage of immunization spend. financed using Government funds?
------------ New and under utilized vaccines introduction -------------
Hepatitis B vaccine integrated in routine immunization schedule
Hib vaccine integrated in routine immunization schedule
Is Measles 2nd dose vaccine integrated into the routine immunization systems?
Mumps vaccine integrated in routine immunization schedule
Pneumococcal vaccine integrated in routine immunization schedule
Rotavirus vaccine integrated in routine immunization schedule
Rubella vaccine integrated in routine immunization schedule
------------ Maternal and neonatal tetanus (NT) elimination -------------
Protection at birth (PAB) against neonatal tetanus
NT eliminated
------------ Polio eradication -------------
Non-polio AFP rate
% adequate specimen
Confirmed polio
------------ Vitamin A -------------
Vitamin A deficiency status
Were Vitamin A supplements distributed with routine services?
Were Vitamin A supplements integrated with campaigns?
------------ Yellow Fever -------------
Member states at risk for Yellow Fever
Yellow Fever in schedule
-------------------------
Y
ear list
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
-------------------------
Primary sort by:
Indicators
Region/Country
Display only indicator(s) with data:
Yes
No
O
K
with the selection.